Japan· JP-4900700X1026
ベレマゲン ゲペルパベク
A medicinal product containing ベレマゲン ゲペルパベク, registered in Japan by クリスタルバイオテック・ジャパン, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ベレマゲン ゲペルパベク
- Manufacturer
- クリスタルバイオテック・ジャパン
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ベレマゲン ゲペルパベク in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVyjuvek 5 10*9 PFU/mlKrystal Biotech Netherlands
- CzechiaVYJUVEKKrystal Biotech Netherlands, B.V., Amsterdam
- SpainVYJUVEK 5 X 10E9 UNIDADES FORMADORAS DE PLACAS/ML EN SUSPENSION Y GEL PARA PREPARACION DE GELKrystal Biotech Netherlands B.V.
- FinlandVyjuvekKrystal Biotech Netherlands B.V.
- FranceVYJUVEK 5 x 1 000 000 000 unités formant plages /mL, de suspension et gel pour gelKRYSTAL BIOTECH NETHERLANDS (PAYS-BAS)
- IrelandVyjuvek 5 x 10⁹ PFU/ml Suspension and gel for gelKrystal Biotech Netherlands B.V.
- IcelandVyjuvekKrystal Biotech Netherlands B.V.
- NetherlandsVyjuvek 5×10^9 plaquevormende eenheden/ml suspensie en gel voor gelKrystal Biotech Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyjuvek
- Liechtenstein · Vyjuvek
- Norway · Vyjuvek
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c29fffaa-671d-4a49-bcf2-0256a87fa10e GET /v1/drugs/c29fffaa-671d-4a49-bcf2-0256a87fa10e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２瓶１組",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4900700X1026",
"category": "外用薬",
"price_yen": 2955232.7,
"generic_name": "ベレマゲン ゲペルパベク",
"product_name_jp": null,
"therapeutic_class": "4900",
"transitional_expiry": null
}See everything about ベレマゲン ゲペルパベク.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.